Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
A Comprehensive Psychological Intervention to Improve Community and Vocational Reintegration Following Burn Injury and Other Trauma
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 19, 2019
A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to Military Sexual Trauma (MST) in Male and Female Military Personnel and Veterans
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 19, 2019
Efficacy of Biomarker-Guided rTMS for Treatment Resistant Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2019
Positive Valence System Function and Reward Exposure Therapy for Late-Life Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2019
Brain Function, Emotions, and Behavior in Healthy Older Adults
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2019
DORA Trial: Phase 3 Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 13, 2019
AGCT1532: Phase 3 Accelerated BEP Trial: A Randomized Phase 3 trial of Accelerated vs Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 22, 2019
Pembrolizumab and Stereotactic Radio Surgery (SRS) of Selected Brain Metastases in Breast Cancer Patients
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 5, 2019
Long term Outcomes of Obese Patients with Gastrointestinal Complications of Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2019
ARO-021: Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 22, 2019